Paradigm Biopharmaceuticals Limited (ASX:PAR)

ASX:PAR Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	239	89	279	224	483	708
Market Cap Growth	-67.97%	-67.97%	24.43%	-53.57%	-31.80%	163.09%
Enterprise Value	222	56	195	170	398	635
Last Close Price	0.61	0.26	0.96	0.93	2.03	3.04
PS Ratio	-	-	-	2829.64	23494.01	-
PB Ratio	9.05	3.75	5.20	5.30	6.17	6.54
P/TBV Ratio	4.28	4.28	5.50	5.69	6.41	6.73
EV/Sales Ratio	-	-	-	2142.53	19352.81	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Asset Turnover	-	-	-	0.00	0.00	-
Quick Ratio	6.83	6.83	4.84	5.93	13.74	32.15
Current Ratio	7.22	7.22	4.89	6.02	13.98	32.21
Return on Equity (ROE)	-151.39%	-151.39%	-108.16%	-65.10%	-36.79%	-12.88%
Return on Assets (ROA)	-86.16%	-86.16%	-63.78%	-44.22%	-27.38%	-10.71%
Return on Capital (ROIC)	-104.26%	-104.26%	-77.47%	-49.13%	-28.69%	-11.05%
Earnings Yield	-24.49%	-65.65%	-18.61%	-17.51%	-7.10%	-1.74%
FCF Yield	-73.81%	-73.81%	-16.20%	-14.37%	-7.24%	-1.44%
Buyback Yield / Dilution	-17.43%	-17.43%	-7.34%	-1.21%	-14.32%	-40.59%
Total Shareholder Return	-17.43%	-17.43%	-7.34%	-1.21%	-14.32%	-40.59%

Source: S&P Capital IQ. Standard template. Financial Sources.